Patients with gastrointestinal conditions, absorption disorders, or post-bariatric surgery may not be ideal candidates for oral formulations
human evidence is still emerging.) Musculoskeletal injury or post-surgical recovery Chronic tendonitis, ligament sprains, or joint pain Athletes or active individuals with overuse injuries Patients with GI inflammation or ulcerative symptoms Individuals seeking regenerative or anti-inflammatory support Generally well-tolerated in available data, but may include: Mild redness or irritation at injection site Transient headache, nausea, or dizziness (rare) Potential for allergic reaction (rare) Not FDA-approved
Visit our website, join the waitlist, and take the first step
Available in BC2 (2mg 10 vials), BC5 (5mg 10 vials), and BC10 (10mg 10 vials), this product offers flexibility for both small-scale assays and extended experimental protocols